Cytochrome P450c17 catalyzes 17a-hydroxylation needed for cortisol synthesis and 17,20 lyase activity needed to produce sex steroids. Serine phosphorylation of 
Introduction
Steroid hormones are synthesized by a set of pathways that begin with the conversion of cholesterol to pregnenolone by mitochondrial cytochrome P450scc, the quantitative regulator of steroidogenesis. Pregnenolone can then be directed to one of three principal pathways by microsomal P450c17, the qualitative regulator of steroidogenesis, which catalyzes both 17a-hydroxylase and 17,20 lyase activities (1) (2) (3) (4) ( Fig. 1) . In the absence of P450c17, e.g. in adrenal zona glomerulosa and ovarian granulosa cells, pregnenolone is converted to 17-desoxy, C21 steroids including progesterone, corticosterone and aldosterone. In the presence of the 17a-hydroxylase activity of P450c17, the adrenal zona fasciculata produces C21 17a-hydroxy steroids including the glucocorticoid cortisol. When both 17a-hydroxylase and 17,20 lyase activities are present, the adrenal zona reticularis and gonads produce the C19 17-ketosteroid dehydroepiandrosterone (DHEA), which is the precursor of androgens and estrogens.
The ratio of the 17a-hydroxylase to 17,20 lyase activities of human P450c17 is developmentally regulated. Adjusted for body size, the human adrenal produces nearly constant amounts of cortisol throughout life, indicating relatively constant 17a-hydroxylase activity (5). By contrast, the production of DHEA is minimal in childhood, phosphatase (19) . We now provide evidence that PP2A serves as the principal phosphatase regulating P450c17 phosphorylation and 17,20 lyase activity.
MATERIALS AND METHODS

Cells and transfection -
The NCI-H295A adherent population (20) of human adrenocortical NCI-H295 tumor cells (21,22) was grown on 150 mm Petri plates as described (20) . Cells at 60-80% confluence were treated with okadaic acid, fostriecin and cantharidin (Calbiochem, www.calbiochem.com). NCI-H295A cells in 100 mm dishes were transfected with 5mg of the plasmids pBJF, pBJF-Flag-PP2A, pBJF-Flag-PP4 or pBJF-Flag-PP6 (23) ) in 50mM potassium phosphate buffer (pH 7.4), containing 100 mM KCl and 0.1 mM EDTA. Unbroken cells, the nuclear fraction and mitochondria were separated at 12,000xg for 20 min and microsomes were pelleted from the 12,000xg supernatant at 100,000xg for 90 min. Microsomes were resuspended in same buffer containing 20% glycerol and used immediately for enzyme assay. 17a-hydroxylase and 17,20 lyase activity assays were as described (15, 24) .
Briefly, microsomes (20 mg protein) were incubated at 37°C with 50,000 cpm of [ 7 microsomal proteins by monitoring the release of free phosphate. PP4 and PP2A were immunoprecipitated and washed three times with 50 mM HEPES buffer (pH 7.4) containing 0.1% Triton X-100 and 500 mM NaCl. Immunoprecipitates were incubated in 100 ml of 50 mM HEPES (pH 7.0), 0.1 mM DTT, 0.1 mM CaCl 2 , 1mM MgCl 2 and 1mM MnCl 2 at 25°C for 30 min, pelleted by centrifugation, and the supernatant was transferred to fresh tubes. The assay was terminated with 500 ml of Biomol Green reagent (Biomol laboratories, www.biomol.com), a phosphate detection reagent based on malachite green, incubated for 20 min at room temperature and read at 620 nm. One unit of phosphatase activity was defined as amount of enzyme required to release 1 nmol of phosphate per hour at 30 °C. For the in vitro PP2A experiments, microsomes were treated with 12.5 U/ml of pure recombinant PP2A catalytic subunit (Promega) at 25°C in 50 mM Tris-HCl (pH 7.4) containing 20 mM MgCl 2 . The reaction was terminated by addition of 1mM okadaic acid and 10 mM NaF and chilling on ice for 10 min.
siRNA construction and transfection -Small interfering RNAs (siRNAs) to the catalytic subunits of human PP2A, and PP4, were designed with 3' overhanging thymidine dimers as described (27) . Target sequences were aligned to the human genome database in a BLAST search (www.ncbi.nlm.nih.gov/blast) to eliminate those with significant similarity to other genes. Web based siRNA design software from Ambion (http://www.ambion.com/techlib/misc/siRNA_finder.html) was used for selecting siRNA sequences. Three target sequences for each gene corresponding to sequences located in the 5', 3', or middle regions of each transcript were synthesized and used for transfection ( Table 1) . The siRNAs were synthesized using a transcription-based Silencer TM siRNA synthesis kit (Ambion, www.ambion.com). Transfection was carried out using the Oligofectamine transfection reagent (Invitrogen) as described (28) . In brief, NCI-H295A cells were grown to 50-70% confluency in complete medium without antibiotics in 100 mM plates. Cells were washed with serum-free medium prior to transfection. All the siRNA duplexes (2.0 mg/100 mm plate) were diluted in separate tubes with 100 ml of Opti-MEM™ (Invitrogen). In separate tube Oligofectamine reagent was diluted 1:5 with Opti-MEM™ medium and incubated for 10 min at room temperature. Diluted Oligofectamine reagent was added to siRNA duplexes (50 ml diluted Oligofectamine reagent / mg of siRNA) and the mixture was incubated for 20 min at room temperature. The volume of medium overlaying the cells was adjusted to 7.5 ml and the siRNA transfection complexes (200 ml) were added; six hours later the medium was supplemented with serum to make a final serum concentration of 2%.
Because of the slow doubling time of NCI-H295A cells (20, 22 ) the cells were then incubated for an additional 72 hr before harvesting for analysis.
Preparation and transfection of rat SETb protein-Full length rat SETb cDNA (29) was sub-cloned into pBluebac His2Sf9 (Invitrogen), and transfected into Spodoptera Sf9 cells for 48 h. Cells (50 ml culture) were collected, washed and lysed in 4 ml of 500 mM NaCl, 25 mM Hepes, pH 7.5 (buffer B) containing 1% Tween 20, 10% glycerol, 1mM pefabloc and a mixture of protease inhibitors. The cell lysate was applied to a 250 ml Ni-NTA column previously equilibrated with buffer B containing 1% Tween 20. The column was first washed with 5ml of buffer B containing 1% Tween 20, then with 5 ml of buffer B, and finally with 5 ml of buffer B containing 5 mM imidazole. The bound SETb was eluted with 5 ml of buffer B containing 250 mM imidazole. Protein transfection into NCI-H295A cells was performed with Chariot reagent (Active Motif, www.activemotif.com).
NCI-H295A cells were plated in 6 well plates and grown to 40-60% confluency. Purified SET protein was diluted with PBS (1.0 mg/ml) and Chariot reagent was diluted with water (1:20) . In a separate tube, 100 ml of diluted SET protein was mixed with 100 ml of diluted Chariot reagent and incubated at room temperature for 30 min. Growth medium from the cells was aspirated and cells were washed with PBS. Transfection complex (200 ml/well) was added to cells, the volume was adjusted to 600 ml with serum-free RPMI-1640 medium, and the cells were incubated for one hour (37 °C, 5% CO 2 ). Cells were supplemented with 1.0 ml complete growth medium and incubation was continued for additional 4 hours after which the cells were harvested and used for experiments.
PCR of human SET and phosphatases -Total RNA (1.0 mg) from NCI-H295A cells was converted to cDNA using Superscript II reverse transcriptase (Invitrogen) for 30 min at 50°C, followed by 35 cycles of PCR amplification (30s at 94°C, 30s at 60°C and 90s at 72°C). Primer pairs are described in Table 2 .
Preparation of endogenous kinases and in vitro phosphorylation -Soluble intracellular kinases were enriched using an ATP-Sepharose matrix (Upstate Biotech) as described (30) . ATP-Sepharose matrix (0.25 ml) was washed three times with 1 ml of 25 mM HEPES, pH 7.4, 150 mM NaCl; 1mM NADH; 1 mM NAD; 1 mM ADP; 1mM AMP; 1 mM DTT and 60 mM MgCl 2 (buffer A). NCI-H295A cells were lysed in 50 mM Tris-HCl pH 7.4 containing 1% NP-40; 5 mM EDTA; 2 mM EGTA; 150 mM NaCl; 1 mM PMSF; 1mg/ml each of aprotinin, leupeptin and pepstatin; 1 mM DTT; 0.15 mM Na 3 VO 4 ; 10 mM NaF; 500 mM cantharidin, 1mM NADH; 1mM NAD; 1mM ADP and 1mM AMP, centrifuged at 100,000 x g for 90 min at 4°C and 1 ml of the soluble fraction (1 mg protein) was added to the washed ATP-Sepharose beads. After incubation for 4 h with agitation at 4°C, the beads were washed 4 times with 0.5 ml of buffer A containing 500 mM NaCl, suspended in 0.5 ml of buffer A containing 10 mM ATP and incubated at room temperature for 60 min to elute bound kinases. Bacterially expressed human Bacterially-expressed human P450c17 -The pCWH17-mod(His)4 expression plasmid containing the cDNA for modified human P450c17 (31), was transformed into E. coli JM109. Ampicillin-resistant colonies were grown at 37°C to OD 600 0.4-0.6, P450c17 expression was induced by 0.4 mM IPTG at 25°C for 48 h, and P450c17 was purified as described (31). In brief, spheroplasts prepared by lysozyme treatment of bacteria were lysed by sonication for 3 min at 30 kCs The action of okadaic acid on NCI-H295A cells was dose-dependent with a half maximal effect on lyase activity at 10 nM and a maximal effect at 100 nM, but there was no effect on 17a hydroxylase activity (Fig 2A) . While it is logical to presume that the action of PP2A to inhibit 17,20 lyase activity was directly attributable to dephosphorylation of P450c17, it could also have resulted from an indirect proteinprotein interaction. To discriminate between these two possibilities, PP2A was preincubated with various concentrations of okadaic acid. The okadaic acid-treated PP2A was added to NCI-H295A microsomes and the 17,20 lyase activity was measured Effect of PP2A and PP4 on P450c17 activities in NCI-H295A microsomes-To identify the specific phosphatases responsible for the effects of the inhibitor treatments, we treated steroidogenically active microsomes from NCI-H295A cells with PP2A and PP4 and assayed 17,20 lyase activity. PP2A (12.5 U/ml) inhibited 17,20 lyase activity to the same extent as alkaline phosphatase (12.5 U/ml), but PP4 (25 U/ml) had no effect (Fig 3A) . This action of PP2A could be partially overcome by pre-treating the PP2A with the phosphoprotein SET (7.8 nM), an inhibitor of PP2A (37) . SET alone did not affect 17,20 lyase activity (not shown). To determine if PP2A was sufficient for removing the physiologically relevant phosphate groups, we treated NCI-H295A microsomes with PP2A ( Fig 3B) . Preincubation of microsomes with up to 12.5 U/ml of PP2A had no effect on the conversion of progesterone to 17OH-Prog (an index of 17a-hydroxylase activity) but PP2A decreased 17,20 lyase activity (conversion of 17OH-Preg to DHEA ) in a dose-dependent manner with a half maximal effect at about 0.5 U/ml, and complete inhibition at 12.5 U/ml. Thus PP2A exerts the same selective effect on the steroid 17, 20 lyase activity of P450c17 that we previously observed with non-specific calf intestinal alkaline phosphatase (18) , but PP4 does not exert this effect. The presence of PP2A, PP4 and SET in NCI-H295A cells was confirmed by western blotting (data not shown).
PP4 and PP6 cannot mimic the action of PP2A-PP2A shares 66% sequence identity with PP4 and 58% identity with PP6, indicating they belong to a related family of phosphatases (38) , and some inhibitors of PP2A also affect PP4 (36, 38) and might potentially inhibit PP6. To determine if the action of PP2A on P450c17 was specific or simply representative of this family of phosphatases, we transfected NCI-H295A cells with expression vectors for the catalytic subunits of PP2A, PP4 or PP6 (23) , verified the expression of these proteins by western blotting, and measured 17,20 lyase activity ( Fig   4A) . Compared to cells transfected with an empty vector, the 17,20 lyase activity of cells expressing PP2A was reduced, whereas the 17,20 lyase activity of cells expressing PP4 and PP6 was unchanged. Thus PP4 and PP6 were unable to dephosphorylate the relevant residues of P450c17.
To determine if PP2A interacts directly with P450c17, we immunoprecipitated PP2A, PP4 and SET from NCI-H295A cells under non-denaturing conditions and confirmed the immunoprecipitation of each by western blotting (not shown). Probing with antisera to P450c17 showed that P450c17 co-immunoprecipitated with PP2A but not with PP4 or SET (Fig 4B) , indicating that the action of PP2A is to dephosphorylate P450c17 itself, and not some other protein that influences P450c17 activity.
Suppression of PP2A by siRNA -To determine whether the effects of PP2A on the 17,20 lyase activity that we had documented with the biochemical assays in vitro were relevant to the regulation of 17,20 lyase activity in cells in vivo we used RNA interference to suppress the expression of the catalytic subunits of PP2A and PP4 in NCI-H295A cells. Three 21 nt siRNA segments directed against the 5' end, the middle, or the 3' end of the mRNAs for PP2A and PP4 were transfected into NCI-H295A cells and the cells were examined 72 hr later. Western blotting showed that both PP2A and PP4 were reduced by half compared to cells transfected with control 21 nt RNAs ( Fig   5A) . Neither transfection with the control RNA or the siRNA directed against PP4 affected 17,20 lyase activity, but transfection with siRNA against PP2A increased 17,20 lyase activity by 250% (Fig 5 B, C (29, 41) and modifying the substrate specificity of PP1 (42) . SET (7.8 nM) inhibited the activity of PP2A but not PP4 using phosphorylated NCI-H295A microsomal proteins as substrate in vitro (Fig 6A) . Because transfection of SET expression vectors inhibited cell cycle, we assayed SET's activity on P450c17 in vivo using a liposome-mediated protein transfection procedure to introduce recombinant rat SETb into NCI-H295A cells (65-75% transfection efficiency; data not shown). Transfection with 25 ng of SET for 4 h increased 17,20 lyase activity to the same degree as treating the cells with 10 nM okadaic acid (Fig 6B) but had no effect on total amount of P450c17 protein detectable by western blot (Fig 6C) . Analysis of NCI-H295A cells by RT-PCR shows they express a wide variety of protein phosphatases (Fig 6D) , and both SETa and SETb (Fig. 6E) , which differ only at their amino termini, due to alternate first exon choice (43); both SETa and SETb can inhibit PP2A activity equally in vitro (44) .
Reactivation of 17,20 lyase activity of NCI-H295A microsomes treated with PP2A
-To confirm that the action of PP2A on 17,20 lyase activity is mediated by dephosphorylating P450c17 rather than by working on some other upstream target, we determined if the 17,20 lyase activity that had been lost to the action of PP2A could be restored by re-phosphorylating P450c17. We prepared NCI-H295A cytoplasmic extract and enriched it for protein kinase activity by affinity chromatography on ATP-Sepharose (30) . The retained fraction lacked phosphatase activity but was enriched for ATPdependent kinase activity. NCI-H295A microsomes were dephosphorylated with PP2A, then the PP2A was inactivated with 100 nM okadaic acid and 10 mM NaF. Under these conditions the microsomes retained 17a-hydroxylase activity but had lost almost all 17,20 lyase activity (Fig. 7A) . Re-phosphorylation of these PP2A-treated microsomes using 10 mM Mg-ATP and the cytosolic fraction enriched for protein kinases (5-10 mg protein) fully restored 17,20 lyase activity (Fig 7A) . Neither the kinase preparation nor the cytosolic fraction of NCI-H295A cells contained significant 17,20 lyase activity ( Fig   7B) . Thus one or more ATP-dependent protein kinases present endogenously in NCI-H295A cell cytoplasm is sufficient to restore full 17,20 lyase activity to dephosphorylated P450c17 in NCI-H295A microsomes.
To determine whether NCI-H295A microsomes contain other unidentified factors required for the phosphorylation of P450c17, we examined the ability of the NCI-H295A cytosolic kinases to phosphorylate purified human P450c17 expressed in bacteria (31). (19) . Different PP2A holoenzymes form at various phases of the cell cycle and during metabolic processes (19, 46, 47) . Okadaic acid, microcystin LR, tautomycin, cantharidin, calyculin A and fostriecin are highly specific inhibitors of the PPP family (36, 38, 48) . The sensitivity of specific cellular process to different concentrations of these inhibitors can facilitate the identification of physiologically relevant phosphatases. Okadaic acid and fostriecin are particularly useful as they can permeate membranes, inhibiting PP1, PP2A and PP4 in intact cells (33, 34, 38) . The sensitivity of the 17,20 lyase reaction to very low concentrations of fostriecin and okadaic acid, both in vivo and in vitro, the sensitivity to SET protein, the inability of PP4 and PP6 to dephosphorylate and inhibit the 17,20 lyase reaction, and the specific effect of suppression of PP2A, but not PP4, by siRNA all strongly suggest a role for PP2A in the regulation of P450c17 phosphorylation and 17,20 lyase activity.
PP2A activity can be regulated by a tyrosine kinase that phosphorylates and inactivates the catalytic subunit (49) and by interaction with SET (37) . SET is also a nuclear protein involved in cell proliferation and inhibiting cyclins (39), and is also known as TAF-1, which regulates adenovirus DNA replication (50). SET also acts as a transcription factor that regulates mouse testicular P450c17 (29, 41 ). SET appears to be an endogenous regulator of PP2A's action on P450c17. SET has been identified as the activity by inhibiting PP2A suggests that it is the first of these factors to be identified.
Similarly, many protein kinases are themselves regulated by complex cascades of phosphorylation and dephosphorylation. Thus we propose that the regulation of the 17,20 lyase activity of P450c17 is positively regulated by a kinase pathway and negatively regulated by a phosphatase pathway, both of which contain multiple components, each of which represent a potential site of regulation (Fig 8) . We previously suggested that IGF-1 is associated with the induction of adrenarche (18) The abbreviations used are: PP2A, Protein phosphatase 2A; PP4, Protein phosphatase 4; PP6, Protein phosphatase 6; PCOS, Polycystic ovary syndrome, DHEA, Dehydroepiandrosterone; OR, P450 oxidoreductase; 17OH-Preg, 17OH-Pregnonolone; 17OH-Prog, 17OH-Progesterone; DSS, Disuccinimidyl suberate; siRNA, small interfering RNA. Table 1 siRNA target sequences and siRNA duplexes. Three target sequences ( base numbers in parenthesis correspond to the position in mRNA sequence) were identified for PP2A and PP4; the synthesized sense and antisense siRNAs are shown below each DNA target. Table 2 RT-PCR primer pairs Table 3 Effect of PP2A inhibitors on 17,20 lyase activity in NCI-H295A microsomes by guest on November 19, 2017 
